DiaGen AI  /  Team

Expert operators and advisors.

100+ years of combined experience across AI, ML, drug discovery, clinical regulation and capital markets — spanning Canada, the U.S., the UK, EU and UAE.

Brian D. KeaneBrian D. KeaneCEO, Chairman

30+ yrs legal + capital markets, $3B+ transactions. Ex-Banker Rodman & Renshaw and Ladenburg Thalmann. Former MD, Yorkville Advisors. JD 2000, NYLS, Certification AI drug discovery, 2023, MIT.

Paolo LoboPaolo LoboPresident / COO

MSc Biochemistry (UBC). 10+ yrs in IVD, crystallography + biotech across business development, regulatory strategy and partnerships. Formerly at Sino Biological + Published in Nature.

Andrew ChanAndrew ChanCFO

Finance and operations leader for early-stage startups. Former Finance Manager at Electronic Arts; Head of Finance at Xtract AI.

Mohit PandeyMohit PandeyChief AI Officer

AI/ML for life sciences, widely published. PhD Bioinformatics (UBC), MS in CS (Rutgers). Formerly Recursion (Nasdaq: RXRX) and Weill Cornell.

Eric BaumEric BaumCo-Founder / Director

20+ yrs advising private + public companies. Co-Founder Solidea Capital, Director Acquis Consulting. Corporate Board Governance Expert. Board Member, Starton Holdings. Valedictorian, Emory U.

Noah El Rimawi-FineNoah El Rimawi-FineML Engineer

Master's at McGill and Mila researching ML for drug discovery, biomolecular design and genetics. BSc Mathematics and Computer Science.

Ivan SemenovIvan SemenovComputational Drug Design

MSc Bioorganic Chemistry (summa cum laude). 4+ yrs in pharma as a computational chemist with Insilico Medicine, Boston Gene. Leads CADD and AI-driven molecule and peptide design.

Dr. Sonny KohliDr. Sonny KohliDirector, Chief Medical Advisor

MD FRCPC. Chief Med Info Officer, Brockville Hospital. Member, Royal College of Physicians. Prof. McMaster Univ. Co-founder, Cloud DX. Winner of Canada's XPRIZE. Former VP, Roche. Astronaut candidate, CSA.

Aditya TallapragadaAditya TallapragadaAdvisor

Founder of AKT Health. 15+ yrs in life sciences and clinical research, applying AI and deeptech to regulatory workflows. Built Impakt Health, a Japan-certified Class II SaMD.

Mike GrantisMike GrantisAdvisor

8+ yrs investing in liquid tokens and private ventures. Co-Founder, Contango Digital Assets + CEO General Tensor. Founder, Crypto Weekly. Associate, Satstreet.

Paul CrathPaul CrathDirector / Legal Advisor

Formerly at White & Case. Currently Partner and Head of Capital Markets at CMX Law, New York. 30+ yrs in capital markets, M&A and cross-border transactions. Bar: New York.

Neil CrabbNeil CrabbAdvisor

CEO of Frontier IP Group (AI/IP focus) and former founding shareholder of Exscientia. Co-founded Sigma Capital, with prior investment management experience in private banking and Equitable Life.

Tech-Bio Partnering: Tools and Deployment

For platform access, catalog partnering or co-development enquiries.

IR@diagen.ai